TAIYO HOLDINGS CO., LTD. (4626) Stock Price

Taiyo Holdings operates primarily through two business segments. In the Electronics business, the company develops, manufactures, and sells chemical materials for electronic components, with a focus on printed circuit board (PCB) materials. These products are used in digital consumer electronics such as PCs, smartphones, servers, and televisions, as well as in automotive-related equipment.

In the Healthcare and Pharmaceutical business, the company manufactures and sells pharmaceutical products for medical use, as well as provides contract manufacturing services. The business began full-scale operations in 2018 and currently offers 19 long-listed pharmaceutical products. The company also manufactures and sells dental laboratory products, expanding its presence in the healthcare sector.

Taiyo Holdings conducts business operations both domestically and internationally. In the Electronics business, key subsidiaries include Taiyo Ink Manufacturing Co., Ltd. and Taiyo Youzai (Suzhou) Co., Ltd. In the Healthcare and Pharmaceutical business, Taiyo Pharma Co., Ltd. and Taiyo Pharmatech Co., Ltd. serve as the core companies.

The company also operates other businesses including the manufacture and sale of dyes, pigments, chemicals, and inks; power generation using renewable energy; food and beverage facility operations; systems engineering services; and systems development. These operations are managed by subsidiaries such as Taiyo Fine Chemical Co., Ltd. and Taiyo Green Energy Co., Ltd.

Taiyō Holdings has established a long-term management vision called "Beyond Imagination 2030" and is advancing its growth strategy. This vision aims to create a future beyond imagination, driven by technological advancement and environmental responsibility. Specifically, the company is focusing on the development of its electronics and healthcare/pharmaceutical businesses, while promoting energy operations and digital transformation.

The company has established seven fundamental policies. First, it prioritizes the development and utilization of autonomous talent, aiming to cultivate personnel capable of adapting to increasingly diverse organizations and society. Additionally, the company is pursuing growth in its electronics business and creation of new business domains, as well as further expansion of its healthcare and pharmaceutical operations. Business evolution through digital transformation is also a key pillar.

Furthermore, Taiyō Holdings is enhancing corporate value through the creation of new businesses and strategic M&A activities. The company is also strengthening its commitment to the SDGs and advancing initiatives that contribute to sustainable development goals. Through these measures, the company aims to maximize shareholder value.

The company has set targets to maintain ROE of 18% and DOE of 5% or higher, prioritizing shareholder returns. To advance its growth strategy toward 2030, the company has established the 2030 Committee to work on improving its management foundation, growth strategy, and governance structure. Through these efforts, the company is pursuing a policy of maximizing long-term corporate value.